Sangamo Therapeutics (SGMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 102,428 | 84,452 | 36,567 | 19,389 | 39,539 |
| Gross Profit | 102,428 | 84,452 | 36,567 | 19,389 | 39,539 |
| Operating Expenses | 207,608 | 161,602 | 92,928 | 91,948 | 86,395 |
| Operating Income | -105,180 | -77,150 | -56,361 | -72,559 | -46,856 |
| Other Income | 9,761 | 8,261 | 1,793 | 887 | 431 |
| Pre-tax Income | -95,419 | -68,889 | -54,568 | -71,672 | -46,425 |
| Income Tax | N/A | N/A | 0 | -14 | -5,722 |
| Net Income Continuous | -95,419 | -68,889 | -54,568 | -71,658 | -40,703 |
| Minority Interests | -233 | -555 | N/A | N/A | N/A |
| Net Income | $-95,186 | $-68,334 | $-54,568 | $-71,658 | $-40,703 |
| EPS Basic Total Ops | -0.85 | -0.70 | -0.70 | -1.02 | -0.58 |
| EPS Basic Continuous Ops | -0.85 | -0.71 | -0.70 | -1.02 | -0.58 |
| EPS Diluted Total Ops | -0.85 | -0.70 | -0.70 | -1.02 | -0.58 |
| EPS Diluted Continuous Ops | -0.85 | -0.71 | -0.70 | -1.02 | -0.58 |
| EPS Diluted Before Non-Recurring Items | -0.85 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-100,281 | $-80,620 | $-55,536 | $-71,341 | $-45,041 |